Summary

Summary

According to APO Research, the global Alternative to Antibiotics market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Alternative to Antibiotics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Alternative to Antibiotics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Alternative to Antibiotics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Alternative to Antibiotics include DSM, BioGaia, Bioriginal, Biosearch Life, China-Biotics, Chr. Hansen, Danone, DuPont(Danisco) and Ganeden, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Alternative to Antibiotics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alternative to Antibiotics.

The report will help the Alternative to Antibiotics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

The Alternative to Antibiotics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Alternative to Antibiotics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Alternative to Antibiotics Segment by Company

DSM
BioGaia
Bioriginal
Biosearch Life
China-Biotics
Chr. Hansen
Danone
DuPont(Danisco)
Ganeden
Glory Biotech
Greentech
Lallemand
Morinaga Milk Industry
Novozymes
Probi
Sabinsa
Synbiotech
UAS Laboratories
Valio
Yakult
Nestle

Alternative to Antibiotics Segment by Type
Antimicrobial Proteins
Bacteriophages
Probiotics
Other

Alternative to Antibiotics Segment by Application
Drugs
Food & Beverage
Dietary Supplements

Alternative to Antibiotics Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alternative to Antibiotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Alternative to Antibiotics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alternative to Antibiotics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Alternative to Antibiotics manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Alternative to Antibiotics by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Alternative to Antibiotics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.

ページTOPに戻る

Table of Contents

1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources

2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Alternative to Antibiotics Market Size (2020-2031)
2.2.2 Global Alternative to Antibiotics Sales (2020-2031)
2.2.3 Global Alternative to Antibiotics Market Average Price (2020-2031)
2.3 Alternative to Antibiotics by Type
2.3.1 Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
2.3.2 Antimicrobial Proteins
2.3.3 Bacteriophages
2.3.4 Probiotics
2.3.5 Other
2.4 Alternative to Antibiotics by Application
2.4.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.4.2 Drugs
2.4.3 Food & Beverage
2.4.4 Dietary Supplements

3 Market Competitive Landscape by Manufacturers
3.1 Global Alternative to Antibiotics Market Competitive Situation by Manufacturers (2020 Versus 2024)
3.2 Global Alternative to Antibiotics Sales (K Units) of Manufacturers (2020-2025)
3.3 Global Alternative to Antibiotics Revenue of Manufacturers (2020-2025)
3.4 Global Alternative to Antibiotics Average Price by Manufacturers (2020-2025)
3.5 Global Alternative to Antibiotics Industry Ranking, 2023 VS 2024 VS 2025
3.6 Global Manufacturers of Alternative to Antibiotics, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Alternative to Antibiotics, Product Type & Application
3.8 Global Manufacturers of Alternative to Antibiotics, Established Date
3.9 Global Alternative to Antibiotics Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition

4 Manufacturers Profiled
4.1 DSM
4.1.1 DSM Company Information
4.1.2 DSM Business Overview
4.1.3 DSM Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
4.1.4 DSM Alternative to Antibiotics Product Portfolio
4.1.5 DSM Recent Developments
4.2 BioGaia
4.2.1 BioGaia Company Information
4.2.2 BioGaia Business Overview
4.2.3 BioGaia Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
4.2.4 BioGaia Alternative to Antibiotics Product Portfolio
4.2.5 BioGaia Recent Developments
4.3 Bioriginal
4.3.1 Bioriginal Company Information
4.3.2 Bioriginal Business Overview
4.3.3 Bioriginal Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
4.3.4 Bioriginal Alternative to Antibiotics Product Portfolio
4.3.5 Bioriginal Recent Developments
4.4 Biosearch Life
4.4.1 Biosearch Life Company Information
4.4.2 Biosearch Life Business Overview
4.4.3 Biosearch Life Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
4.4.4 Biosearch Life Alternative to Antibiotics Product Portfolio
4.4.5 Biosearch Life Recent Developments
4.5 China-Biotics
4.5.1 China-Biotics Company Information
4.5.2 China-Biotics Business Overview
4.5.3 China-Biotics Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
4.5.4 China-Biotics Alternative to Antibiotics Product Portfolio
4.5.5 China-Biotics Recent Developments
4.6 Chr. Hansen
4.6.1 Chr. Hansen Company Information
4.6.2 Chr. Hansen Business Overview
4.6.3 Chr. Hansen Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
4.6.4 Chr. Hansen Alternative to Antibiotics Product Portfolio
4.6.5 Chr. Hansen Recent Developments
4.7 Danone
4.7.1 Danone Company Information
4.7.2 Danone Business Overview
4.7.3 Danone Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
4.7.4 Danone Alternative to Antibiotics Product Portfolio
4.7.5 Danone Recent Developments
4.8 DuPont(Danisco)
4.8.1 DuPont(Danisco) Company Information
4.8.2 DuPont(Danisco) Business Overview
4.8.3 DuPont(Danisco) Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
4.8.4 DuPont(Danisco) Alternative to Antibiotics Product Portfolio
4.8.5 DuPont(Danisco) Recent Developments
4.9 Ganeden
4.9.1 Ganeden Company Information
4.9.2 Ganeden Business Overview
4.9.3 Ganeden Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
4.9.4 Ganeden Alternative to Antibiotics Product Portfolio
4.9.5 Ganeden Recent Developments
4.10 Glory Biotech
4.10.1 Glory Biotech Company Information
4.10.2 Glory Biotech Business Overview
4.10.3 Glory Biotech Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
4.10.4 Glory Biotech Alternative to Antibiotics Product Portfolio
4.10.5 Glory Biotech Recent Developments
4.11 Greentech
4.11.1 Greentech Company Information
4.11.2 Greentech Business Overview
4.11.3 Greentech Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
4.11.4 Greentech Alternative to Antibiotics Product Portfolio
4.11.5 Greentech Recent Developments
4.12 Lallemand
4.12.1 Lallemand Company Information
4.12.2 Lallemand Business Overview
4.12.3 Lallemand Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
4.12.4 Lallemand Alternative to Antibiotics Product Portfolio
4.12.5 Lallemand Recent Developments
4.13 Morinaga Milk Industry
4.13.1 Morinaga Milk Industry Company Information
4.13.2 Morinaga Milk Industry Business Overview
4.13.3 Morinaga Milk Industry Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
4.13.4 Morinaga Milk Industry Alternative to Antibiotics Product Portfolio
4.13.5 Morinaga Milk Industry Recent Developments
4.14 Novozymes
4.14.1 Novozymes Company Information
4.14.2 Novozymes Business Overview
4.14.3 Novozymes Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
4.14.4 Novozymes Alternative to Antibiotics Product Portfolio
4.14.5 Novozymes Recent Developments
4.15 Probi
4.15.1 Probi Company Information
4.15.2 Probi Business Overview
4.15.3 Probi Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
4.15.4 Probi Alternative to Antibiotics Product Portfolio
4.15.5 Probi Recent Developments
4.16 Sabinsa
4.16.1 Sabinsa Company Information
4.16.2 Sabinsa Business Overview
4.16.3 Sabinsa Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
4.16.4 Sabinsa Alternative to Antibiotics Product Portfolio
4.16.5 Sabinsa Recent Developments
4.17 Synbiotech
4.17.1 Synbiotech Company Information
4.17.2 Synbiotech Business Overview
4.17.3 Synbiotech Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
4.17.4 Synbiotech Alternative to Antibiotics Product Portfolio
4.17.5 Synbiotech Recent Developments
4.18 UAS Laboratories
4.18.1 UAS Laboratories Company Information
4.18.2 UAS Laboratories Business Overview
4.18.3 UAS Laboratories Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
4.18.4 UAS Laboratories Alternative to Antibiotics Product Portfolio
4.18.5 UAS Laboratories Recent Developments
4.19 Valio
4.19.1 Valio Company Information
4.19.2 Valio Business Overview
4.19.3 Valio Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
4.19.4 Valio Alternative to Antibiotics Product Portfolio
4.19.5 Valio Recent Developments
4.20 Yakult
4.20.1 Yakult Company Information
4.20.2 Yakult Business Overview
4.20.3 Yakult Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
4.20.4 Yakult Alternative to Antibiotics Product Portfolio
4.20.5 Yakult Recent Developments
4.21 Nestle
4.21.1 Nestle Company Information
4.21.2 Nestle Business Overview
4.21.3 Nestle Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
4.21.4 Nestle Alternative to Antibiotics Product Portfolio
4.21.5 Nestle Recent Developments

5 Global Alternative to Antibiotics Market Scenario by Region
5.1 Global Alternative to Antibiotics Market Size by Region: 2020 VS 2024 VS 2031
5.2 Global Alternative to Antibiotics Sales by Region: 2020-2031
5.2.1 Global Alternative to Antibiotics Sales by Region: 2020-2025
5.2.2 Global Alternative to Antibiotics Sales by Region: 2026-2031
5.3 Global Alternative to Antibiotics Revenue by Region: 2020-2031
5.3.1 Global Alternative to Antibiotics Revenue by Region: 2020-2025
5.3.2 Global Alternative to Antibiotics Revenue by Region: 2026-2031
5.4 North America Alternative to Antibiotics Market Facts & Figures by Country
5.4.1 North America Alternative to Antibiotics Market Size by Country: 2020 VS 2024 VS 2031
5.4.2 North America Alternative to Antibiotics Sales by Country (2020-2031)
5.4.3 North America Alternative to Antibiotics Revenue by Country (2020-2031)
5.4.4 United States
5.4.5 Canada
5.5 Europe Alternative to Antibiotics Market Facts & Figures by Country
5.5.1 Europe Alternative to Antibiotics Market Size by Country: 2020 VS 2024 VS 2031
5.5.2 Europe Alternative to Antibiotics Sales by Country (2020-2031)
5.5.3 Europe Alternative to Antibiotics Revenue by Country (2020-2031)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Netherlands
5.5.9 Nordic Countries
5.6 Asia Pacific Alternative to Antibiotics Market Facts & Figures by Country
5.6.1 Asia Pacific Alternative to Antibiotics Market Size by Country: 2020 VS 2024 VS 2031
5.6.2 Asia Pacific Alternative to Antibiotics Sales by Country (2020-2031)
5.6.3 Asia Pacific Alternative to Antibiotics Revenue by Country (2020-2031)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Southeast Asia
5.7 South America Alternative to Antibiotics Market Facts & Figures by Country
5.7.1 South America Alternative to Antibiotics Market Size by Country: 2020 VS 2024 VS 2031
5.7.2 South America Alternative to Antibiotics Sales by Country (2020-2031)
5.7.3 South America Alternative to Antibiotics Revenue by Country (2020-2031)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Alternative to Antibiotics Market Facts & Figures by Country
5.8.1 Middle East and Africa Alternative to Antibiotics Market Size by Country: 2020 VS 2024 VS 2031
5.8.2 Middle East and Africa Alternative to Antibiotics Sales by Country (2020-2031)
5.8.3 Middle East and Africa Alternative to Antibiotics Revenue by Country (2020-2031)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE

6 Segment by Type
6.1 Global Alternative to Antibiotics Sales by Type (2020-2031)
6.1.1 Global Alternative to Antibiotics Sales by Type (2020-2031) & (K Units)
6.1.2 Global Alternative to Antibiotics Sales Market Share by Type (2020-2031)
6.2 Global Alternative to Antibiotics Revenue by Type (2020-2031)
6.2.1 Global Alternative to Antibiotics Sales by Type (2020-2031) & (US$ Million)
6.2.2 Global Alternative to Antibiotics Revenue Market Share by Type (2020-2031)
6.3 Global Alternative to Antibiotics Price by Type (2020-2031)

7 Segment by Application
7.1 Global Alternative to Antibiotics Sales by Application (2020-2031)
7.1.1 Global Alternative to Antibiotics Sales by Application (2020-2031) & (K Units)
7.1.2 Global Alternative to Antibiotics Sales Market Share by Application (2020-2031)
7.2 Global Alternative to Antibiotics Revenue by Application (2020-2031)
7.2.1 Global Alternative to Antibiotics Sales by Application (2020-2031) & (US$ Million)
7.2.2 Global Alternative to Antibiotics Revenue Market Share by Application (2020-2031)
7.3 Global Alternative to Antibiotics Price by Application (2020-2031)

8 Value Chain and Sales Channels Analysis of the Market
8.1 Alternative to Antibiotics Value Chain Analysis
8.1.1 Alternative to Antibiotics Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Alternative to Antibiotics Production Mode & Process
8.2 Alternative to Antibiotics Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Alternative to Antibiotics Distributors
8.2.3 Alternative to Antibiotics Customers

9 Global Alternative to Antibiotics Analyzing Market Dynamics
9.1 Alternative to Antibiotics Industry Trends
9.2 Alternative to Antibiotics Industry Drivers
9.3 Alternative to Antibiotics Industry Opportunities and Challenges
9.4 Alternative to Antibiotics Industry Restraints

10 Report Conclusion
11 Disclaimer

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
Table 4. Market Value Comparison by Application (2020 VS 2024 VS 2031) & (US$ Million)
Table 5. Global Alternative to Antibiotics Volume and Revenue Market Size and CAGR of Manufacturers (2020 Versus 2024)
Table 6. Global Alternative to Antibiotics Sales (K Units) of Manufacturers (2020-2025)
Table 7. Global Alternative to Antibiotics Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Alternative to Antibiotics Revenue of Manufacturers (2020-2025)
Table 9. Global Alternative to Antibiotics Revenue Share by Manufacturers (2020-2025)
Table 10. Global Market Alternative to Antibiotics Average Price (US$/Unit) of Manufacturers (2020-2025)
Table 11. Global Alternative to Antibiotics Industry Ranking, 2023 VS 2024 VS 2025
Table 12. Global Manufacturers of Alternative to Antibiotics, Manufacturing Sites & Headquarters
Table 13. Global Manufacturers of Alternative to Antibiotics, Product Type & Application
Table 14. Global Alternative to Antibiotics Manufacturers Established Date
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Alternative to Antibiotics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2024)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 18. DSM Company Information
Table 19. DSM Business Overview
Table 20. DSM Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 21. DSM Alternative to Antibiotics Product Portfolio
Table 22. DSM Recent Developments
Table 23. BioGaia Company Information
Table 24. BioGaia Business Overview
Table 25. BioGaia Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 26. BioGaia Alternative to Antibiotics Product Portfolio
Table 27. BioGaia Recent Developments
Table 28. Bioriginal Company Information
Table 29. Bioriginal Business Overview
Table 30. Bioriginal Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 31. Bioriginal Alternative to Antibiotics Product Portfolio
Table 32. Bioriginal Recent Developments
Table 33. Biosearch Life Company Information
Table 34. Biosearch Life Business Overview
Table 35. Biosearch Life Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 36. Biosearch Life Alternative to Antibiotics Product Portfolio
Table 37. Biosearch Life Recent Developments
Table 38. China-Biotics Company Information
Table 39. China-Biotics Business Overview
Table 40. China-Biotics Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 41. China-Biotics Alternative to Antibiotics Product Portfolio
Table 42. China-Biotics Recent Developments
Table 43. Chr. Hansen Company Information
Table 44. Chr. Hansen Business Overview
Table 45. Chr. Hansen Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 46. Chr. Hansen Alternative to Antibiotics Product Portfolio
Table 47. Chr. Hansen Recent Developments
Table 48. Danone Company Information
Table 49. Danone Business Overview
Table 50. Danone Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 51. Danone Alternative to Antibiotics Product Portfolio
Table 52. Danone Recent Developments
Table 53. DuPont(Danisco) Company Information
Table 54. DuPont(Danisco) Business Overview
Table 55. DuPont(Danisco) Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 56. DuPont(Danisco) Alternative to Antibiotics Product Portfolio
Table 57. DuPont(Danisco) Recent Developments
Table 58. Ganeden Company Information
Table 59. Ganeden Business Overview
Table 60. Ganeden Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 61. Ganeden Alternative to Antibiotics Product Portfolio
Table 62. Ganeden Recent Developments
Table 63. Glory Biotech Company Information
Table 64. Glory Biotech Business Overview
Table 65. Glory Biotech Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 66. Glory Biotech Alternative to Antibiotics Product Portfolio
Table 67. Glory Biotech Recent Developments
Table 68. Greentech Company Information
Table 69. Greentech Business Overview
Table 70. Greentech Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 71. Greentech Alternative to Antibiotics Product Portfolio
Table 72. Greentech Recent Developments
Table 73. Lallemand Company Information
Table 74. Lallemand Business Overview
Table 75. Lallemand Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 76. Lallemand Alternative to Antibiotics Product Portfolio
Table 77. Lallemand Recent Developments
Table 78. Morinaga Milk Industry Company Information
Table 79. Morinaga Milk Industry Business Overview
Table 80. Morinaga Milk Industry Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Morinaga Milk Industry Alternative to Antibiotics Product Portfolio
Table 82. Morinaga Milk Industry Recent Developments
Table 83. Novozymes Company Information
Table 84. Novozymes Business Overview
Table 85. Novozymes Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 86. Novozymes Alternative to Antibiotics Product Portfolio
Table 87. Novozymes Recent Developments
Table 88. Probi Company Information
Table 89. Probi Business Overview
Table 90. Probi Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 91. Probi Alternative to Antibiotics Product Portfolio
Table 92. Probi Recent Developments
Table 93. Sabinsa Company Information
Table 94. Sabinsa Business Overview
Table 95. Sabinsa Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 96. Sabinsa Alternative to Antibiotics Product Portfolio
Table 97. Sabinsa Recent Developments
Table 98. Synbiotech Company Information
Table 99. Synbiotech Business Overview
Table 100. Synbiotech Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 101. Synbiotech Alternative to Antibiotics Product Portfolio
Table 102. Synbiotech Recent Developments
Table 103. UAS Laboratories Company Information
Table 104. UAS Laboratories Business Overview
Table 105. UAS Laboratories Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 106. UAS Laboratories Alternative to Antibiotics Product Portfolio
Table 107. UAS Laboratories Recent Developments
Table 108. Valio Company Information
Table 109. Valio Business Overview
Table 110. Valio Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 111. Valio Alternative to Antibiotics Product Portfolio
Table 112. Valio Recent Developments
Table 113. Yakult Company Information
Table 114. Yakult Business Overview
Table 115. Yakult Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 116. Yakult Alternative to Antibiotics Product Portfolio
Table 117. Yakult Recent Developments
Table 118. Nestle Company Information
Table 119. Nestle Business Overview
Table 120. Nestle Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 121. Nestle Alternative to Antibiotics Product Portfolio
Table 122. Nestle Recent Developments
Table 123. Global Alternative to Antibiotics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 124. Global Alternative to Antibiotics Sales by Region (2020-2025) & (K Units)
Table 125. Global Alternative to Antibiotics Sales Market Share by Region (2020-2025)
Table 126. Global Alternative to Antibiotics Sales by Region (2026-2031) & (K Units)
Table 127. Global Alternative to Antibiotics Sales Market Share by Region (2026-2031)
Table 128. Global Alternative to Antibiotics Revenue by Region (2020-2025) & (US$ Million)
Table 129. Global Alternative to Antibiotics Revenue Market Share by Region (2020-2025)
Table 130. Global Alternative to Antibiotics Revenue by Region (2026-2031) & (US$ Million)
Table 131. Global Alternative to Antibiotics Revenue Market Share by Region (2026-2031)
Table 132. North America Alternative to Antibiotics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 133. North America Alternative to Antibiotics Sales by Country (2020-2025) & (K Units)
Table 134. North America Alternative to Antibiotics Sales by Country (2026-2031) & (K Units)
Table 135. North America Alternative to Antibiotics Revenue by Country (2020-2025) & (US$ Million)
Table 136. North America Alternative to Antibiotics Revenue by Country (2026-2031) & (US$ Million)
Table 137. Europe Alternative to Antibiotics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 138. Europe Alternative to Antibiotics Sales by Country (2020-2025) & (K Units)
Table 139. Europe Alternative to Antibiotics Sales by Country (2026-2031) & (K Units)
Table 140. Europe Alternative to Antibiotics Revenue by Country (2020-2025) & (US$ Million)
Table 141. Europe Alternative to Antibiotics Revenue by Country (2026-2031) & (US$ Million)
Table 142. Asia Pacific Alternative to Antibiotics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 143. Asia Pacific Alternative to Antibiotics Sales by Country (2020-2025) & (K Units)
Table 144. Asia Pacific Alternative to Antibiotics Sales by Country (2026-2031) & (K Units)
Table 145. Asia Pacific Alternative to Antibiotics Revenue by Country (2020-2025) & (US$ Million)
Table 146. Asia Pacific Alternative to Antibiotics Revenue by Country (2026-2031) & (US$ Million)
Table 147. South America Alternative to Antibiotics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 148. South America Alternative to Antibiotics Sales by Country (2020-2025) & (K Units)
Table 149. South America Alternative to Antibiotics Sales by Country (2026-2031) & (K Units)
Table 150. South America Alternative to Antibiotics Revenue by Country (2020-2025) & (US$ Million)
Table 151. South America Alternative to Antibiotics Revenue by Country (2026-2031) & (US$ Million)
Table 152. Middle East and Africa Alternative to Antibiotics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 153. Middle East and Africa Alternative to Antibiotics Sales by Country (2020-2025) & (K Units)
Table 154. Middle East and Africa Alternative to Antibiotics Sales by Country (2026-2031) & (K Units)
Table 155. Middle East and Africa Alternative to Antibiotics Revenue by Country (2020-2025) & (US$ Million)
Table 156. Middle East and Africa Alternative to Antibiotics Revenue by Country (2026-2031) & (US$ Million)
Table 157. Global Alternative to Antibiotics Sales by Type (2020-2025) & (K Units)
Table 158. Global Alternative to Antibiotics Sales by Type (2026-2031) & (K Units)
Table 159. Global Alternative to Antibiotics Sales Market Share by Type (2020-2025)
Table 160. Global Alternative to Antibiotics Sales Market Share by Type (2026-2031)
Table 161. Global Alternative to Antibiotics Revenue by Type (2020-2025) & (US$ Million)
Table 162. Global Alternative to Antibiotics Revenue by Type (2026-2031) & (US$ Million)
Table 163. Global Alternative to Antibiotics Revenue Market Share by Type (2020-2025)
Table 164. Global Alternative to Antibiotics Revenue Market Share by Type (2026-2031)
Table 165. Global Alternative to Antibiotics Price by Type (2020-2025) & (US$/Unit)
Table 166. Global Alternative to Antibiotics Price by Type (2026-2031) & (US$/Unit)
Table 167. Global Alternative to Antibiotics Sales by Application (2020-2025) & (K Units)
Table 168. Global Alternative to Antibiotics Sales by Application (2026-2031) & (K Units)
Table 169. Global Alternative to Antibiotics Sales Market Share by Application (2020-2025)
Table 170. Global Alternative to Antibiotics Sales Market Share by Application (2026-2031)
Table 171. Global Alternative to Antibiotics Revenue by Application (2020-2025) & (US$ Million)
Table 172. Global Alternative to Antibiotics Revenue by Application (2026-2031) & (US$ Million)
Table 173. Global Alternative to Antibiotics Revenue Market Share by Application (2020-2025)
Table 174. Global Alternative to Antibiotics Revenue Market Share by Application (2026-2031)
Table 175. Global Alternative to Antibiotics Price by Application (2020-2025) & (US$/Unit)
Table 176. Global Alternative to Antibiotics Price by Application (2026-2031) & (US$/Unit)
Table 177. Key Raw Materials
Table 178. Raw Materials Key Suppliers
Table 179. Alternative to Antibiotics Distributors List
Table 180. Alternative to Antibiotics Customers List
Table 181. Alternative to Antibiotics Industry Trends
Table 182. Alternative to Antibiotics Industry Drivers
Table 183. Alternative to Antibiotics Industry Restraints
Table 184. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Alternative to Antibiotics Product Image
Figure 5. Global Alternative to Antibiotics Revenue (US$ Million), 2020 VS 2024 VS 2031
Figure 6. Global Alternative to Antibiotics Market Size (2020-2031) & (US$ Million)
Figure 7. Global Alternative to Antibiotics Sales (2020-2031) & (K Units)
Figure 8. Global Alternative to Antibiotics Average Price (US$/Unit) & (2020-2031)
Figure 9. Antimicrobial Proteins Product Image
Figure 10. Bacteriophages Product Image
Figure 11. Probiotics Product Image
Figure 12. Other Product Image
Figure 13. Drugs Product Image
Figure 14. Food & Beverage Product Image
Figure 15. Dietary Supplements Product Image
Figure 16. Global Alternative to Antibiotics Revenue Share by Manufacturers in 2024
Figure 17. Global Manufacturers of Alternative to Antibiotics, Manufacturing Sites & Headquarters
Figure 18. Global Top 5 and 10 Alternative to Antibiotics Players Market Share by Revenue in 2024
Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Alternative to Antibiotics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. Global Alternative to Antibiotics Sales by Region in 2024
Figure 22. Global Alternative to Antibiotics Revenue by Region in 2024
Figure 23. North America Alternative to Antibiotics Market Size by Country in 2024
Figure 24. North America Alternative to Antibiotics Sales Market Share by Country (2020-2031)
Figure 25. North America Alternative to Antibiotics Revenue Market Share by Country (2020-2031)
Figure 26. United States Alternative to Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Canada Alternative to Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe Alternative to Antibiotics Market Size by Country in 2024
Figure 29. Europe Alternative to Antibiotics Sales Market Share by Country (2020-2031)
Figure 30. Europe Alternative to Antibiotics Revenue Market Share by Country (2020-2031)
Figure 31. Germany Alternative to Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. France Alternative to Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. U.K. Alternative to Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Italy Alternative to Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Netherlands Alternative to Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Nordic Countries Alternative to Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Asia Pacific Alternative to Antibiotics Market Size by Country in 2024
Figure 38. Asia Pacific Alternative to Antibiotics Sales Market Share by Country (2020-2031)
Figure 39. Asia Pacific Alternative to Antibiotics Revenue Market Share by Country (2020-2031)
Figure 40. China Alternative to Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Japan Alternative to Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. South Korea Alternative to Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. India Alternative to Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Australia Alternative to Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. China Taiwan Alternative to Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Southeast Asia Alternative to Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Southeast Asia Alternative to Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. South America Alternative to Antibiotics Market Size by Country in 2024
Figure 49. South America Alternative to Antibiotics Sales Market Share by Country (2020-2031)
Figure 50. South America Alternative to Antibiotics Revenue Market Share by Country (2020-2031)
Figure 51. Mexico Alternative to Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Brazil Alternative to Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Argentina Alternative to Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Middle East and Africa Alternative to Antibiotics Market Size by Country in 2024
Figure 55. Middle East and Africa Alternative to Antibiotics Sales Market Share by Country (2020-2031)
Figure 56. Middle East and Africa Alternative to Antibiotics Revenue Market Share by Country (2020-2031)
Figure 57. Turkey Alternative to Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. Saudi Arabia Alternative to Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 59. UAE Alternative to Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 60. Global Alternative to Antibiotics Sales Market Share by Type (2020-2031)
Figure 61. Global Alternative to Antibiotics Revenue Market Share by Type (2020-2031)
Figure 62. Global Alternative to Antibiotics Price (US$/Unit) by Type (2020-2031)
Figure 63. Global Alternative to Antibiotics Sales Market Share by Application (2020-2031)
Figure 64. Global Alternative to Antibiotics Revenue Market Share by Application (2020-2031)
Figure 65. Global Alternative to Antibiotics Price (US$/Unit) by Application (2020-2031)
Figure 66. Alternative to Antibiotics Value Chain
Figure 67. Alternative to Antibiotics Production Mode & Process
Figure 68. Direct Comparison with Distribution Share
Figure 69. Distributors Profiles
Figure 70. Alternative to Antibiotics Industry Opportunities and Challenges